1 / 27

Sentinel Lymph Node Concept; and Technique of SLN Identification in Breast Cancer Patients

Sentinel Lymph Node Concept; and Technique of SLN Identification in Breast Cancer Patients. Dr S.Gambhir Department of Nuclear Medicine S.G.P.G.I.M.S Lucknow. These PowerPoint presentations are free to download only for academic purposes, with due acknowledgements to authors and this website.

boaz
Télécharger la présentation

Sentinel Lymph Node Concept; and Technique of SLN Identification in Breast Cancer Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sentinel Lymph Node Concept; and Technique of SLN Identification in Breast Cancer Patients Dr S.Gambhir Department of Nuclear Medicine S.G.P.G.I.M.S Lucknow These PowerPoint presentations are free to download only for academic purposes, with due acknowledgements to authors and this website.

  2. Axillary Lymph Node Dissection (ALND) in Carcinoma Breast • Axillary clearance for local disease control • Prognosis

  3. Early Carcinoma Breast • Histopathological positivity of axilla on ALND 30% ~40% • 60-70% patients of primary carcinoma breast patients are undergoing unnecessary ALND • ALND associated morbidity • ? Adjuvant chemotherapy

  4. Technical Issues in SLN Detection and Imaging • What tracer ? • What injection site ? • Large or small volume. • How many MBq’s ?

  5. Technical Issues in SLN Detection and Imaging What is most appropriate site of injection • Subareolar • Peritumoral • Intratumoral • Subdermal • Subcutaneous

  6. Concept of Single Injection • Lymphatic drainage of breast consists of dermal and parenchymal lymphatics which meet at Subareolar lymphatics which meet at subareolar plexus of Sappey. • This further drain through one or two major lymphatic trunk to axilla. • Position of this lymphatic plexus gives the opportunity of single uniformally consistent subareolar injection of injection of radiopharmaceutical/blue dye into breast lymphatics. • Adjuvant Systemic therapy

  7. Radioactive but non blue lymph node

  8. Invitro demonstration of radioactive but non blue lymph node

  9. Results • Imaging + ve 84.8% • Probe +ve 97.3% • Blue dye +ve 91.4% • Concordance between probe and blue dye 94.4% • SLN histopathology 97.2 % (accuracy) (H.E. matched with axilla nodes)

  10. Technical Issues in SLN Detection and Imaging Which mode of detection is preferable ? • Probe detection and imaging • Probe detection only • Blue dye alone or in combination with probe detection

  11. Best Method of SNB Mapping?

  12. Positive Non-Sentinel Axillary Nodes in Patients with Positive Sentinel Nodes

  13. Technical Issues in SLN Detection and Imaging What pathological evidence is required? • Fine-needle aspiration cytology • Imprint cytology • H.E. Staining alone • Cytokeratin immunohistochemistry

  14. Conclusion • Currently detection of SLN is highly accurate in context of carcinoma breast. • There is rapidly increasing database population. • Training programmers relevant to multidisciplinary teams need to be developed for this methodology.

More Related